Syria's Ancient Adobe Houses Threatened by War, Displacement

The village once had more than 3,000 residents but, after fighting raged there, 'everyone left', says a local man - AFP
The village once had more than 3,000 residents but, after fighting raged there, 'everyone left', says a local man - AFP
TT

Syria's Ancient Adobe Houses Threatened by War, Displacement

The village once had more than 3,000 residents but, after fighting raged there, 'everyone left', says a local man - AFP
The village once had more than 3,000 residents but, after fighting raged there, 'everyone left', says a local man - AFP

Traditional mud-brick houses that the people of northern Syria have built for thousands of years risk disappearing, as 12 years of war have emptied villages and left the buildings crumbling.

Also knowns as "beehive houses", the conical adobe structures are designed to keep cool in the blazing desert sun, while their thick walls also retain warmth in the winter.

Umm Amuda Kabira village in Aleppo province is among a handful of places where residents long used to live in the small domed houses, made of mud mixed with brittle hay.

"Our village once had 3,000 to 3,500 residents and some 200 mud houses," said Mahmud al-Mheilej, standing beside deserted homes with weeds growing out of the roofs.

"Everyone left" after the region saw heavy fighting and was overrun by Islamic State group jihadists, the schoolteacher in his 50s told AFP.

Aleppo province was the scene of fierce battles between Syrian government forces, opposition and ISIS extremists from 2012 until Russian-backed government forces gradually ousted them.

While the violence has waned in the area, instability and economic hardship have long become a fact of life across Syria.

"No more than 200 of us have returned" to the village, said Mheilej, who now lives in a concrete building close by.

Inside one traditional house, crevasses snaked along white walls riddled with holes.

All of the mud-brick homes have been abandoned, Mheilej said, pointing at a tumbledown wall, the remnants of a collapsed house.

"There is no one left to take care of the houses, that's why they are decaying," he added. "In time, they will disappear without a trace."

Syria's war broke out in 2011 and quickly escalated into a conflict that pulled in foreign powers and militants.

The fighting has killed more than 500,000 people, and millions have been displaced.

"We were born and raised inside the mud houses," said Jamal al-Ali, 66, from outside the ancestral home his family was forced to abandon in nearby Haqla.

The domed structure kept inhabitants cool in the summer and warm in the winter, said Ali, as he shared a meal with his family on a straw carpet.

Local masons were among those who fled the fighting, leaving the region short of their ancestral know-how.

Issa Khodr, 58, who took refuge in neighbouring Lebanon, is one of the last Syrians with expertise in building the structures, which require regular upkeep.

With support from local charity Arcenciel, he has recreated the rustic dwellings in the Bekaa Valley, home to a large Syrian refugee population.

"I learnt the trade in the village when I was 14 because every time someone wanted to build a mud house, others would help," said the former civil servant.

"Because of the war, the houses are disappearing, and so is our profession," said Khodr.

Lebanese architect Fadlallah Dagher said the construction technique "is believed to have originated during the Neolithic period some 8,000 years ago".

The project aims to pass on knowledge among the refugees, Dagher said, so that "once they return to their devastated country, which lacks resources, they can build their own homes".



FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
TT

FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights

US health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.

The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis, The AP reported.

Anaphylaxis occurs when the body's immune system develops a sudden, unexpected reaction to a foreign substance, such as food, insect stings or medications. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing.

The device, marketed as Neffy, could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers. Anaphylaxis sends more than 30,000 people to emergency rooms and results in more than 2,000 hospitalizations and more than 230 deaths in the US each year.

Of the 6 million prescriptions written for auto-injectors each year, more than 40% are never filled, Dr. Thomas Casale, an allergist at the University of South Florida, told an FDA advisory panel last year. Even when they are available to caregivers, many auto-injectors are used incorrectly, he said.

“There’s a real unmet medical need for a large portion of the population,” he said.

Neffy is intended for people who weigh at least 66 pounds. It is given in a single dose sprayed into one nostril. A second dose can be given if the person’s symptoms don’t improve.

The new treatment could be life-changing for people with severe food allergies, said Dr. Kelly Cleary, a pediatrician and director with the Food Allergy Research & Education, a nonprofit advocacy group.

“I have seen the look of worry or fear,” said Cleary, whose 11-year-old son has multiple food allergies. “I worry about what happens if someone hesitates.”

Requiring an injection in an emergency is as scary to some children as the allergic reaction itself. Some parents have had to restrain thrashing children to inject them, sometimes causing cuts that require stitches. About 3,500 caregivers a year are injured when they accidentally inject themselves in the hands, ARS said.

Priscilla Hernandez, of Pasadena, California said her 12-year-old son, Zacky, who is allergic to sesame, peanuts, tree nuts, avocado and other foods, was traumatized when he had a reaction at school about six years ago and a nurse treated him with an auto-injector.

“Having to do a shot creates this whole different level of anxiety,” she said.

She said, “we are over the moon” about the FDA's approval of the spray, which Zacky will start carrying when it becomes available.

First marketed in 1901, epinephrine predates the FDA itself. Products like the EpiPen auto-injector, approved in 1987, were authorized based on chemistry and manufacturing data and were not required to prove safety and efficacy.

Clinical trials of people experiencing potentially deadly reactions are difficult for ethical and pragmatic reasons. Instead, ARS officials compared the effect of the nasal spray on biological markers to existing epinephrine treatments.

Results showed Neffy worked about as well as injected epinephrine to boost heart rate and blood pressure, which counter severe reactions. The drug is combined with a patented agent that allows it to be easily absorbed through nasal membranes.